Evidence map›Paper›PMID 33633240›Full record

Observational studyScientific reports2021

Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral blood.

Hélène Péré, Raphael Vernet, Simon Pernot, Juliette Pavie, Nicolas Robillard, Julien Puech, Sonia Lameiras, Marie-Laure Lucas, Alain Nicolas, Cécile Badoual and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Hélène Péré *Laboratoire de virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 20-40 rue Leblanc, 75015, Paris, France.
Raphael Vernet *Département d'Informatique Médicale, Biostatistiques et Santé Publique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Simon PernotOncologie médicale, Institut Bergonié, Unicancer, Bordeaux, France.
Juliette PavieService d'Immunologie clinique, Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France.
Nicolas RobillardLaboratoire de virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 20-40 rue Leblanc, 75015, Paris, France.
Julien PuechInstitut du Fer à moulin, Inserm UMRS 839, Université Pierre et Marie Curie, Paris, France.
Sonia LameirasPlateforme NGS-ICGex, Institut Curie, SIRIC, Paris, France.
Marie-Laure LucasService d'Immunologie clinique, Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France.
Alain NicolasInstitut Curie, Centre de Recherche, CNRS UMR3244, Université PSL, Paris, France.
Cécile BadoualINSERM U970, PARCC, Hôpital Européen Georges Pompidou, Faculté de Médecine, Centre université de Paris, Paris, France.
Bastien RanceDépartement d'Informatique Médicale, Biostatistiques et Santé Publique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Laurent BélecLaboratoire de virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 20-40 rue Leblanc, 75015, Paris, France.
Laurence WeissService d'Immunologie clinique, Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France.
Maxime WackDépartement d'Informatique Médicale, Biostatistiques et Santé Publique, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
David VeyerLaboratoire de virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, 20-40 rue Leblanc, 75015, Paris, France. david.veyer@aphp.fr.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Scientifique · FRInstitut Bergonié · FRInstitut Curie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Archival tissue samples collected longitudinally from a patient who died from HPV16-induced high-grade anal intraepithelial squamous cell carcinoma with vertebral HPV16-positive metastasis were retrospectively analyzed by the Capture-HPV method (Capt-HPV) followed by Next-Generation Sequencing (NGS). Full length nucleotide sequences of the same HPV16 were identified from the initial and second anal biopsy samples, from plasma sample and from vertebral metastasis biopsy. Remarkably, HPV was episomal in each sample. The HPV genome sequence was closest to the HPV16 Qv18158E variant subtype (A1 lineage) exhibiting base substitutions and deletions in 7 and 2 HPV loci, respectively. In conclusion, the powerful Capt-HPV followed by NGS allows evidencing the detailed cartography of tumoral and circulating HPV DNA, giving rise to a unique and unexpected episomal virus molecular status in a context of aggressive carcinoma, underlying the importance of HPV status and its association with clinical features for further prospective studies.

Indexed as

Neoplasm MetastasisAnus NeoplasmsCarcinoma, Squamous CellHuman papillomavirus 16HumansPapillomavirus InfectionsRetrospective Studies

Identifiers

PMID33633240
PMCPMC7907240
OpenAlexW3131570717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.